Neurocrine Biosciences
NBIX
#1576
Rank
C$18.18 B
Marketcap
C$181.23
Share price
2.56%
Change (1 day)
9.29%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Earnings for Neurocrine Biosciences (NBIX)

Earnings in 2025 (TTM): C$0.87 Billion

According to Neurocrine Biosciences 's latest financial reports the company's current earnings are C$2.86 Billion. , an increase over its 2024 earnings that were of C$0.84 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neurocrine Biosciences from 1996 to 2025

Annual earnings

Year Earnings Change
2025 C$0.87 B3.9%
2024 C$0.84 B96.41%
2023 C$0.43 B41.13%
2022 C$0.30 B73.74%
2021 C$0.17 B-8.82%
2020 C$0.19 B77.78%
2019 C$0.10 B49.83%
2018 C$72.38 M-142.57%
2017 -C$0.18 Billion-14.73%
2016 -C$0.2 Billion53.15%
2015 -C$0.14 Billion46.25%
2014 -C$89.03 Million29.66%
2013 -C$68.66 Million-3530.8%
2012 C$2 M-95.73%
2011 C$46.88 M
2009 -C$65.91 Million-45.38%
2008 -C$0.13 Billion-58.87%
2007 -C$0.3 Billion87.3%
2006 -C$0.16 Billion351.97%
2005 -C$34.66 Million-52.09%
2004 -C$72.33 Million-10.98%
2003 -C$81.25 Million
2001 -C$60.65 Million
1999 -C$27.36 Million108.32%
1998 -C$13.13 Million
1996 C$4 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$14.08 B 1,501.26%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$9.11 B 936.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$35.56 B 3,942.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
C$0.11 B-86.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-C$57.72 Million-106.56%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
C$69.86 M-92.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-C$6.63 Million-100.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
C$2.25 B 156.38%๐Ÿ‡ฌ๐Ÿ‡ง UK